Literature DB >> 11742857

ApoA-II versus ApoA-I: two for one is not always a good deal.

L W Castellani, A J Lusis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742857

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  6 in total

1.  Gender-specific associations between apolipoprotein A1 and arterial stiffness in patients with nonalcoholic fatty liver disease.

Authors:  Xulong Sun; Ruifang Chen; Guangyu Yan; Zhiheng Chen; Hong Yuan; Wei Huang; Yao Lu
Journal:  PeerJ       Date:  2020-08-18       Impact factor: 2.984

2.  Post-transcriptional nature of uremia-induced downregulation of hepatic apolipoprotein A-I production.

Authors:  Hamid Moradi; Hamid M Said; Nosratola D Vaziri
Journal:  Transl Res       Date:  2012-12-03       Impact factor: 7.012

3.  Levels of apolipoprotein A-II in cerebrospinal fluid in patients with neuroborreliosis are associated with lipophagocytosis.

Authors:  L Táborský; P Adam; O Sobek; M Dostál; J Dvoráková; L Dubská
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

4.  Swapping the N- and C-terminal domains of human apolipoprotein E3 and AI reveals insights into their structure/activity relationship.

Authors:  Mark T Lek; Siobanth Cruz; Nnejiuwa U Ibe; Wendy H J Beck; John K Bielicki; Paul M M Weers; Vasanthy Narayanaswami
Journal:  PLoS One       Date:  2017-06-23       Impact factor: 3.240

5.  β3-Adrenoceptor activation upregulates apolipoprotein A-I expression in HepG2 cells, which might further promote cholesterol efflux from macrophage foam cells.

Authors:  Xia-Qing Gao; Yan-Fang Li; Zhi-Li Jiang
Journal:  Drug Des Devel Ther       Date:  2017-03-03       Impact factor: 4.162

6.  P465L-PPARγ mutation confers partial resistance to the hypolipidaemic action of fibrates.

Authors:  Sergio Rodriguez-Cuenca; Stefania Carobbio; Gwendolyn Barceló-Coblijn; Xavier Prieur; Joana Relat; Ramon Amat; Mark Campbell; Ana Rita Dias; Myriam Bahri; Sarah L Gray; Antonio Vidal-Puig
Journal:  Diabetes Obes Metab       Date:  2018-06-27       Impact factor: 6.577

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.